Edition: International | Greek
MENU

Home » EU Actually

European Parliament helps VDL to conceal a dubious 35 billion euros deal

European Commission President Ursula von der Leyen has been suspected of a conflict of interest for years

By: N. Peter Kramer - Posted: Wednesday, January 24, 2024

Meanwhile, the majority of the European Parliament does not want the contracts with Pfizer to be revealed. This leaves the Pfizer contract, which involved 35 billion euros and 1.8 billion vaccines under lock and key.
Meanwhile, the majority of the European Parliament does not want the contracts with Pfizer to be revealed. This leaves the Pfizer contract, which involved 35 billion euros and 1.8 billion vaccines under lock and key.

N. Peter Kramer’s Weekly Column

European Commission President Ursula von der Leyen has been suspected of a conflict of interest for years. In March 2021 she made, without consulting the commission, a dubious deal with Pfizer CEO Albert Bourla through private negotiations. She, on her own, purchased 1,8 billion corona vaccines. This was far too many, many had to be thrown away or donated. A total of around 35 billion euros would have been involved in the deal.

At least 215 million vaccines, worth 4 billion euros, have been thrown away, unused by EU member states, according to calculations by Politico. The member states are stuck with strangulation contracts. They must continue to buy Pfizer’s vaccines until 2027, otherwise Pfizer will file a lawsuit against them. This is currently happening with Hungary and Poland.

Von der Leyen refuses to give any transparency about the deal. That is why she has been reprimanded several times by EU Ombudsman Emily O’Reilly. For instance, an investigation, launched in January 2022, unveiled that all Von der Leyen’s possible relevant text messages disappeared from her phone.

The European Court of Auditors also wants clarification, but has never received it. Meanwhile, the majority of the European Parliament does not want the contracts with Pfizer to be revealed. This leaves the Pfizer contract, which involved 35 billion euros and 1.8 billion vaccines under lock and key.

Ursula von der Leyen can breathe a sigh of relief…

READ ALSO

EU Actually

European Parliament challenges member-states with an additional budget increase of 10 percent

N. Peter KramerBy: N. Peter Kramer

In his weekly column, N. Peter Kramer writes how the EP opposes Commission’s proposal to cut back on traditional programmes such as agriculture and cohesion

Europe

The EU–India Deal Is Done. Africa Must Be Next

The EU–India Deal Is Done. Africa Must Be Next

The EU-India FTA deal showed Brussels can move when the stakes are high; Africa is the real test of whether Europe can protect its economic security in a more fractured world.

Business

Where Romania can build excellence: the sources of future competitiveness

Where Romania can build excellence: the sources of future competitiveness

Romania has been, for most of its recent history, a story of potential deferred. The standard account of Romanian competitiveness, to the extent one exists in international business literature, is a cost story: cheap labor, low corporate taxes, a large domestic market for Central and Eastern European standards.

MARKET INDICES

Powered by Investing.com
All contents © Copyright EMG Strategic Consulting Ltd. 1997-2026. All Rights Reserved   |   Home Page  |   Disclaimer  |   Website by Theratron